首页> 外国专利> Method of manufacturing peptide from korean native cattle meat and composition for preventing treating or improving the hypertension or neurodegenerative disease comprising the peptide from korean native cattle meat using thereof

Method of manufacturing peptide from korean native cattle meat and composition for preventing treating or improving the hypertension or neurodegenerative disease comprising the peptide from korean native cattle meat using thereof

机译:由韩国天然牛肉生产肽的方法和用于预防或改善高血压或神经退行性疾病的组合物,其包含由韩国天然牛肉生产的肽

摘要

The present invention relates to a method for producing a peptide derived from beef, and to a composition for preventing, treating or improving hypertension or degenerative neurological disease comprising a beef-derived peptide prepared therefrom as an active ingredient. According to the method of manufacturing the beef-derived peptide of the present invention, there is no risk of denatured protein because of no additional process or chemical treatment that is harmful to human body, and the protein can be separated in high yield while maintaining its original properties. Enzymes used for the production of beef-derived peptides can be purchased and used at low cost, and there is no difference in degree of hydrolysis from general commercial enzymes, so that beef-derived peptides can be produced economically and efficiently using the enzymes. In addition, the beef-derived hydrolyzate or peptide according to the present invention is derived from natural materials and has no toxicity and side effects, and has been shown to exhibit angiotensin converting enzyme inhibitory effect and neuronal cell protective effect, preventing or treating hypertension or degenerative neurological disease. It is expected to be usefully used as a composition for improvement, or the like.
机译:本发明涉及一种生产源自牛肉的肽的方法,以及涉及一种预防,治疗或改善高血压或变性神经疾病的组合物,该组合物包含由其制备的牛肉衍生的肽作为活性成分。根据本发明的牛肉来源的肽的制造方法,由于不存在对人体有害的额外的处理或化学处理,因此不存在蛋白质变性的风险,并且可以在维持蛋白质含量的同时高收率地分离蛋白质。原始属性。可以廉价地购买和使用用于生产牛肉来源的肽的酶,并且与一般的商业酶的水解程度没有差异,因此可以使用该酶经济且有效地生产牛肉来源的肽。另外,本发明的牛肉来源的水解产物或肽衍生自天然材料并且没有毒性和副作用,并且已经显示出具有血管紧张素转化酶抑制作用和神经元细胞保护作用,预防或治疗高血压或退行性神经疾病。预期可以有效地用作用于改进的组合物等。

著录项

  • 公开/公告号KR102081852B1

    专利类型

  • 公开/公告日2020-02-26

    原文格式PDF

  • 申请/专利权人 중앙대학교 산학협력단;

    申请/专利号KR20180092547

  • 发明设计人 허선진;이승연;

    申请日2018-08-08

  • 分类号C07K14/47;A23L33/18;A61K38/17;A61P25/28;A61P9/12;C07K1/12;

  • 国家 KR

  • 入库时间 2022-08-21 11:05:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号